Tags |
|
|
Links |
|
|
Answers - Need Cheap Loan: Go for Low Interest Rates Loans
As the caption itself indicates, low interest rate loans are the loans offered by finance companies/lenders to borro
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
wers for various purposes at low rate of interest.
Broadly, there are two types of loan-Secured loans and unsecured
Broadly, there are two types of loan-Secured loans and unsecured
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
Loans. Secured loans are those, which require you to offer the lender any of your assets, most commonly a house, as
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
collateral. For lenders, this collateral serves as a security against defaults in payments by the borrower. If you,
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
as a borrower, do not pay back the money borrowed by you to the lender, lenders have the power and authority to enc
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ash the collateral to recover their payments.
Therefore, such loans are called secured loans. Contrary to secured l
Therefore, such loans are called secured loans. Contrary to secured l
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
oans, to avail unsecured loan, borrowers do not need to offer any collateral. Therefore, the lenders have more risk
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
n unsecured loans than in secured. To compensate the increased risk in case of unsecured loan, lenders charge higher
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
rate of interest in such loans. Where in case of secured loans, lenders charge low rate of interest due to low risk
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
element.
Now-a-day, financing companies have started low interest rate loans in case of unsecured loans also, whic
Now-a-day, financing companies have started low interest rate loans in case of unsecured loans also, whic
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
h effectively means, between the two lenders one may offer a lower rate of interest than the other. The lower rate o
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
f interest in case of the first lender makes the loan cheaper than the loan offered by the second lender.
Low inter
Low inter
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
est rate loans are available in most of the types of loans such as secured and unsecured home loan, auto loan, perso
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
nal loan etc among others. However, to borrow a low interest rate loan, borrowers need to fulfill certain criteria,
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ome of which are:
I. Offer collateral as security in case of secured loan.
II. Should be in service or self-em
I. Offer collateral as security in case of secured loan.
II. Should be in service or self-em
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ployed
III. Must be living in the current house for more than a year.
IV. Should have a clean bank stateme
III. Must be living in the current house for more than a year.
IV. Should have a clean bank stateme
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
nt.
V. Should have good credit score.
VI. Should not be a defaulter previously.
VII. Any proof of suc
V. Should have good credit score.
VI. Should not be a defaulter previously.
VII. Any proof of suc
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
cessfully closing any loan previously. This adds the most in borrower’s profile, which results in lower interest rat
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
e.
VIII. Two references.
Lenders request for the above criteria to establish the credibility of the borrower a
VIII. Two references.
Lenders request for the above criteria to establish the credibility of the borrower a
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
nd so the risk associated with the loan offered to you. In case of low risk, lenders always charge low interest rate
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/108059/answers-Need-Cheap-Loan-Go-for-Low-Interest-Rates-Loans.html">Need Cheap Loan: Go for Low Interest Rates Loans</a>
BB link (for phorums):
[url=http://www.answers.org.ua/article/108059/answers-Need-Cheap-Loan-Go-for-Low-Interest-Rates-Loans.html]Need Cheap Loan: Go for Low Interest Rates Loans[/url]
Related Articles:
Five Principles of Effective Communication
The Most Important Business Aspect - Marketing
Bookmark it:
|